Socioeconomic status (SES) is a significant sociodemographic correlate of noncontraceptive hormone therapy, yet multiple dimensions of SES have not been examined systematically in previous studies of hormone therapy. This study examined the lifetime incidence of noncontraceptive hormone therapy, how usage varied by type of reproductive organ surgery, and the bivariate and net associations between a large array of SES indicators and the likelihood of ever using hormones by age 53-54 years in a population sample (n = 3,612) of non-Hispanic white female participants in the Wisconsin Longitudinal Study . Approximately half of the women had ever used noncontraceptive hormones; 38.5% were current users. In multivariate logistic regression analyses, the most robust SES predictor of hormone therapy was a woman's husband's occupational status (higher status associated with higher rates of use), after adjustment for all other measured sociologic and biomedical factors (e.g., other SES measures, other health behaviors, menopausal symptoms, age at menopause, health insurance). The association of hormone therapy with education differed between women wfio underwent hysterectomy and/or oophorectomy (higher odds for less educated women) and those with intact reproductive organs (lower odds for less educated women). Additionally, a woman's own earnings and household net worth were positive net correlates of noncontraceptive hormone therapy. Am J
The use of noncontraceptive hormone therapy has increased during the past two decades in the United States, as well as in many other countries in the developed world (1) . Both national and regional US epidemiologic studies found higher rates of therapeutic hormone use in the late 1980s and the 1990s than in the late 1970s (2) (3) (4) (5) . Prevalence estimates of hormone therapy have ranged widely, depending on the sampling frame of the study (1, 3, 6) . The lifetime incidence of estrogen use reported by a national sample of US women born between 1897 and 1950 who had become postmenopausal by 1992 was 45 percent (2) . Nonconrraceptive hormone therapy is the most prescribed pharmaceutical treatment among midlife American women (7).
Contemporary women must decide whether to use noncontraceptive hormone therapy in a social context of conflicting ideological perspectives regarding its promotion (8) (9) (10) (11) (12) (13) (14) (15) and continuing controversy about its advisability as a therapeutic, preventive, or palliative health behavior (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) . Nonetheless, hormone therapy has been advocated for its potential contribution to reduced risks of osteoporosis (26, 27) and cardiovascular disease (17, 28) .
The most significant sociodemographic correlate of noncontraceptive hormone therapy other than sex, age, and race (2, 23) is socioeconomic status (SES). Higher rates of hormone therapy have been found among women with higher household incomes (3, 29) . Evidence regarding the association between educational level and hormone therapy is inconsistent: Some studies find higher educational attainment to be associated with higher rates of hormone therapy (5, 23, 30, 31) or with prolonged use of hormones (2) ; others find no association with ever using hormones (2, 3, 29) . To our knowledge, SES differences in hormone therapy have not been studied with evaluation of multiple measures of SES concurrently (e.g., years of education, occupational status, and income) or with differentiation between measures of parental SES, spousal SES, and individual SES.
While SES is often positively associated with health-promoting behaviors and good health outcomes (32) (33) (34) (35) (36) (37) (38) (39) , considerable debate continues regarding the processes whereby SES influences differences in health behavior and health status (33, 40, 41) . Different measures of SES are only moderately correlated, and each measure captures different attributes of social status. One research approach to elucidating the possible processes underlying any given SES-health relation is examination of multiple measures of SES simultaneously, allowing for an assessment of which measure(s) yield the largest net associations (42) (43) (44) (45) (46) (47) . Such an approach can 1) lead to a more reliable and accurate charting of SES differences in health-related outcomes and 2) guide future data collection, both national and small-scale, to include the most operative measures of SES (48) (49) (50) .
The strongest biomedical correlate of noncontraceptive hormone therapy is surgical menopause (2, 3, 5, 6, (29) (30) (31) 51) . Use of hormones has been associated with the presence of menopausal symptoms (6, 30) and with health behavior indicators, such as exercise, alcohol consumption, smoking, and body mass index (2-4, 6, 22, 51, 52) . Selection into estrogen use by women with more positive health behavior profiles for cardiovascular disease may explain why some studies have found a beneficial relation between use of hormones and reduced risk of cardiovascular disease (22, 23, 53) .
The goal of this study was to provide a more differentiated understanding of the relation between SES and use of noncontraceptive hormone therapy among midlife women. Toward this end, we: 1) examined the incidence of hormone therapy and how it varied by surgery status and age at menopause in a large population sample studied longitudinally from age 18 to age 53 years; 2) examined bivariate associations between a large array of women's parental, spousal, and personal SES indicators and hormone therapy; and 3) examined a series of multivariate models that provided information about the relative net importance of multiple SES indicators for predicting therapeutic hormone use by age 53-54 years.
MATERIALS AND METHODS

Sample
Data from the Wisconsin Longitudinal Study , a long-term study of a random sample of the Wisconsin high school graduating class of 1957 (n = 10,317), were used for this analysis. In 1992-1993, during the most recent data coDection period, when respondents were approximately 53 or 54 years old, 10,031 (97.2 percent) of the original 1957 sample of men and women were located. An hour-long telephone interview was completed by 89.8 percent of living respondents (n = 8,493), and a 20-page mailback survey was completed by 80.9 percent of telephone respondents {n = 6,875). The data used for this paper came from 3,612 non-Hispanic white women (70.9 percent of the living female respondents from the 1957 sample) who completed both the telephone interview and the mail-back survey in 1992-1993 (54) .
Measures
Hormone use. In a series of questions about menopause, all mail-back survey respondents were asked, "Have you ever taken hormones or birth control pills for menopausal or aging symptoms?" Nearly half (49 percent) of the women in the sample reported ever using hormones (see table 1 ). In additional analyses (not shown), we found that 38.5 percent of the sample women were current users. Among women who had ever used hormones, 96.7 percent of women who had not had reproductive organ surgery reported beginning use of hormones at age 40 or older, and more than half reported beginning it at age 50 or older. Among women who reported undergoing removal of the uterus and/or ovaries, self-reported age at onset of hormone therapy was either concurrent with or subsequent to reproductive organ surgery. This evidence suggests that our question about hormone therapy measured hormone use related to hormone depletion, not contraceptive hormone use. Unfortunately, no further verification of hormone use was available in these data.
Surgery status. Women who responded to the mail-back survey received one of two versions of questions on women's health and menopause. The two versions of the questionnaire did not vary with regard to most items. In the first version, women were asked whether they had gone through menopause or were currently going through menopause. Those who answered "yes" were asked, "Was menopause induced or hastened by a hysterectomy (surgical removal of your uterus and/or ovaries)?" The second version asked directly, "Have you ever had surgery to remove your uterus and/or ovaries?" and elicited from respondents information on all surgical procedures that applied to them. Female respondents reporting surgery on the first version of the questionnaire were coded 1 for the variable "surgery (old form)." Women reporting surgery on the second version were coded according to the specific kind of surgery they had undergone: hysterectomy only, hysterectomy plus oophorectomy, or oophorectomy only. Approximately 29 percent of our sample indicated that they had had some type of reproductive organ surgery, which is comparable to a national estimate of about 34 percent of US women aged 50-54 years in 1985 (55) For assessment of menstrual status, all women were asked, "Have you had a menstrual period in the last 12 months?" Women who answered "no" were then asked how old they were when they had their last period. Women who answered "yes" were coded as still menstruating. For these analyses, women were grouped by their age at menopause (see table 1 ). Socioeconomic status. Measures of father's educational attainment and mother's educational attainment were provided by respondents in 1975. Father's occupational status was also reported by respondents in 1975; it was measured by the Duncan Socioeconomic Index (SEI) male-based score for 1970 US Census occupation and industry categories (56) (57) (58) . This same SEI index was the basis for determination of spouse's occupational status in 1975 and respondent's occupational status in 1975. Since the SEI is based on job-level education and earnings, it is only moderately associated with individual-level education and earnings; e.g., the correlation (r) between respondent women's educational level and their 1975 SEI score was 0.46. Parents' income was computed using information obtained from Social Security records for parents around the year 1957.
Respondent's educational attainment was based on the respondent's report of the last year of completed schooling as of 1992-1993. Respondent's occupational status in 1975 was measured using the (1970) SEI rating of the respondent's report of her current or last job at the time of the 1975 survey. Only 2.5 percent of the women had never worked as of 1975 and could not be coded on this variable; these few female cases were flagged as "never worked" on a dichotomous variable included in the analyses.
Respondent's 1974 income and spouse's 1974 income were based on respondent reports made in 1975 of respondent and spousal income (if married) in 1974. Net worth in 1993 was calculated by summing the estimated value minus any outstanding debt that respondents reported for several kinds of personal property and other assets. These data were not collected in 1975, so it was not possible to construct a causally prior measure of net worth with these data. Net worth captures additional variation in affluence and lifestyle that is missing from more volatile measures of yearly income. Home ownership was a dichotomous measure indicating whether a respondent owned her own home (mortgaged or not) in 1992-1993.
Additional predictors. Mental ability was based on the respondent's Henmon-Nelson intelligence score as measured during the junior year of high school (obtained from school records). Including an ability measure enabled us to better estimate the net effect of education above and beyond its association with personal differences in cognitive performance.
Marital status in 1993 was obtained from telephone survey reports in 1992-1993. Since use of hormones is so closely linked to reproductive behavior and reproductive organ health, we included measures of parity status in our analyses. Number of biologic children was reported in 1992-1993. Age at first birth was computed from respondents' responses to fertility history questions posed in 1975 and 1992-1993. A variable for "three children by age 24" was included in the analyses, because it has been associated with a higher likelihood of hysterectomy (59) .
During the sequence of menopausal questions, women were asked, 'To what extent do or did you experience the following menopausal symptoms?": bone pains, depression, hot flashes, night sweats, and sleep disturbances (possible responses were "not at all," "a little," "somewhat," and "a lot"). Dichotomous measures for these symptoms were constructed, where women who reported ever having a menopausal symptom at least "a little" were coded 1. The relatively high rates of self-reported "menopausal symptoms" recorded here must be considered cautiously, since these reports are personal, often retrospective attributions of a symptom experience to menopause across a range of years (whatever the respondent considered the menopausal transition period); they include the reported presence of even a slight degree of a symptom, and should not be used to estimate the incidence of these symptoms attributable to menopause per se.
Health insurance status was assessed in 1992-1993. Health-related behaviors included were: binge drinking (a dichotomous variable for which consuming more than five alcoholic drinks on any one occasion in the past month was coded 1); vigorous exercise (a dichotomous variable for which a report of vigorous exercise (such as aerobics, running, swimming, bicycling, etc.) three or more times per week was coded 1); smoking status (where former smokers and current smokers were contrasted with never smokers); and body mass index (weight (kg)/height (m) 2 , where underweight (<19), overweight (>25 and <29), and obesity (^29) were contrasted with normal weight (>19 and <25)).
Statistical analysis
Logistic regression models yielding maximum likelihood estimates were used for all analyses. Respondents who indicated that they had ever taken hormones were contrasted with those who had not. Initially, individual predictors or a related cluster of predictors were examined. In subsequent stepwise models, all predictors were examined net of the effects of all the others. began our analysis by examining the associations between use of hormones, surgery status, and age at which menstrual periods stopped (naturally or due to surgery), including interaction terms for surgery (any type) X age at which periods stopped. As expected, we found that women who had had any type of reproductive organ surgery were significantly more likely to report ever having used hormones (table 2, model 1, first section). Information obtained from respondents to the second version of the questionnaire provided evidence that type of surgery also made a difference. The odds ratio for hormone use associated with combined hysterectomy and oophorectomy versus no surgery was 3.03. The odds of hormone use for hysterectomy only and for oophorectomy only versus no surgery were similar to each other-both were about 1.80.
We also found significant differences associated with age at which menstrual periods stopped. The main effects for age at which periods stopped indicated that menopause prior to age 40 for nonsurgery women significantly increased the odds of hormone use in contrast to nonsurgery women whose periods stopped at the more typical ages of 49-51 years. It is notable that among women who had undergone surgery, having surgery prior to age 40 or at ages 43-45 was associated with a reduction in the odds of taking hormones. Although it might have been expected that surgery at an earlier age would be associated with a greater likelihood of hormone use, this birth cohort of women reached the ages of 35-45 around the years 1975-1985-a time period of heightened concern about the risks of hormone therapy and of declining rates of hormone use (2) . Because of the complexity of these associations, we created figure 1 to better illustrate the relative odds of hormone use among the Wisconsin women based on these two variables. Using a woman who did not have surgery and whose periods stopped at the modal age of menopause (ages [49] [50] [51] as the baseline, figure 1 indicates that the highest odds ratio of hormone use, 3.17, was for the women who underwent combined hysterectomy and oophorectomy at ages 46-48 years (calculated by multiplying the three relevant odds ratios from model 1 (table 2): 3.03 X 1.08 X 0.97). Thus, at least for this cohort, for procedures of any type, having surgery at an age very close to the expected age of menopause was associated with a greater likelihood of hormone use than having surgery at a younger age.
SES predictors of hormone use
Next we examined the effects of our multiple SES indicators one at a time (in each case, adjusting for age at which periods stopped and surgery type-our baseline model) on the likelihood of hormone use. Each of the sections delimited by a solid line in the first column of table 2 (model 1) describes estimates from a separately fitted model. In each case, we first estimated odds ratios using a model that included the variable and its interaction with surgery status (variable X surgery status). If none of the interactions was statistically significant (p < 0.05), we reestimated the odds ratios using a model without interactions (together with the baseline model).
The results of these analyses yielded evidence that among the SES indicators, hormone use was positively associated with father's educational attainment, mother's educational attainment (among women who had surgery), parents' income, father's occupational status, respondent's educational attainment, respondent's occupational status, respondent's income, spouse's income, net worth, and home ownership. Women who were married at age 53-54 years, women who associated some degree of depression or sleep disturbance with menopause, women who were former smokers (in contrast to never smokers), and women who were normal weight (in contrast to obese) also used hormones at higher rates.
Since several significant associations between parental SES characteristics and use of hormones emerged when separate models were examined, we next estimated odds ratios using a model that included all of the parental SES indicators simultaneously, along with a new baseline model that included age at which periods stopped, surgery, and age periods stopped X surgery interactions. The odds ratio estimates from this model (table 2, model 2) suggested that the effect of father's education was accounted for by other parental characteristics: mother's education, father's occupational status, and parents' income. The effects of mother's education for women who had surgery and the effects of parental income and father's occupational status remained significant. The odds ratios for all categories of surgery increased by approximately one third when we controlled for parental SES in model 2 compared with model 1. The effect of surgery on hormone use was suppressed when SES was not controlled; this result is convergent with what we might have expected, knowing that hysterectomy is more common among lower SES women (60) (61) (62) and that lower SES women are less likely to use hormones.
In a subsequent model (not shown), we added respondent's own educational attainment to the previous model. Overall, the effects of parents' SES and respondent's SES as measured by educational attainment on hormone use appeared to be independent of each other. In the next model (model 3), we added the t p <! 0.10; * p S 0.05; ** p<. 0.01; ••• p <; 0.001 (two-tafled testa). X For detailed definitions of variables, see "Materials and Methods." § Results for each panel of estimates in column labeled 'Model 1" are adjusted for age at which menstrual periods stopped and type of surgery. All odds ratios were estimated in models using appropriate flags for missing values. D Reference category. # "Not married in 1975" was also included in the "bivariate" model for spousal income with a non-statistically significant estimated odds ratio, 1.34.
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mental ability measure to examine whether a woman's education was a proxy for her mental ability. These results indicated that mental ability was not a strong net predictor of hormone use. The effects of parents' SES and respondent's educational attainment remained relatively constant when mental ability was controlled. These findings appear to refute the hypothesis that differences in mental ability explain the pos- itive association between hormone use and educational attainment. We added respondent's occupational status and income in model 4 to examine whether the life course pathway through which parental and respondent SES influenced hormone use was associated with respondent's occupational status and earnings. These results (model 4) indicated that net of parental SES and respondent's education, respondent's occupational status and income were not major independent predictors of hormone use.
By contrast, when we added spouse's occupational status, spouse's income, and net worth and home ownership in 1993 to the next model (model 5), we found that spouse's occupational status was a strong predictor of hormone use net of other factors. The odds of using hormones among women whose husbands were employed in a job in the lowest quintile of occupational status were reduced 22 percent in comparison with women with husbands in the highest quintile of occupational status. Controlling spouse's occupational status and income also revealed significant effects of women's own earnings on hormone use. Lower levels of net worth reduced the odds of hormone use in contrast to the highest net worth category after adjustment for other factors. Additional analyses (not shown) confirmed that none of the effects for SES variables previously included were changed substantially by the sole addition of net worth.
Our final model (model 6) added family variables (i.e., currently being married, parity, and age at first birth), menopausal symptoms, health insurance, and health-related behaviors. Adjusting for all other factors, many SES factors continued to predict hormone usage. For women who had undergone surgery, having a less educated mother decreased the odds of hormone use. Having one's father's occupation in the lowest and middle quintiles of the distribution versus the highest quintile decreased the odds of using hormones. Among women who had undergone surgery, respondents with educational attainment of some college had increased odds of hormone use in contrast to those with a college degree. Being in the second quintile of respondent's occupational status (versus the highest quintile) and being in the lower three fifths of the income distribution (versus the highest quintile) decreased the odds of hormone use. Having a husband in any of the four lowest quintiles (versus the highest quintile) of the occupational status distribution at age 35 years and having a net worth less than $200,000 (versus $400,000 or more) at age 53-54 years decreased the odds of ever using hormones.
Numerous biomedical measures also remained independent predictors of hormone use. Having any kind of reproductive surgery increased the odds of hormone use. Being younger at cessation of menstrual periods for nonsurgically menopausal women increased the odds of ever using hormones, but being younger at cessation for surgically menopausal women had the opposite effect. Respondents who associated some degree of depression or sleep disturbance (trend effect) with menopause had higher odds of hormone use. Current smokers as compared with never smokers had decreased odds of ever using hormones, while former smokers versus never smokers had increased odds of hormone use. These differences in hormone use by smoking status probably captured the fact that smoking status is a contraindicator for hormone use. Finally, being obese decreased the odds of using hormones.
DISCUSSION
Almost half of our sample of midlife women had used noncontraceptive hormone therapy. As expected, we found differences in ever having used hormones according to how menstruation ceased (surgically or naturally) and when menopause took place (figure 1). While both of these factors have been found to vary by SES-lower SES women in the United States have more surgery (60) (61) (62) and earlier surgical and nonsurgical menopause (63) than higher SES women-the associations of surgery and menopausal timing with hormone use held up even when we controlled multiple dimensions of SES. Furthermore, associations of SES with hormone use persisted net of each other and net of surgery and menopausal timing. We suspect that each of our SES indicators could have had stronger observed associations with hormone use had we not controlled for surgery and age at cessation of menstrual periods in all of our models.
These are important considerations to bear in mind when comparing our results with those of other studies. In particular, many epidemiologic studies which examine SES and hormone therapy only report the observed bivariate association between SES and hormone therapy and do not simultaneously control other factors, such as menopausal and surgical history (for a notable exception, see Brett and Madans (2)), other SES measures, and family structural factors.
Our sample had limitations in generalizability due to its regional basis, its birth cohort specificity, and its restriction to non-Hispanic white women with at least a high school education. While we believe that our results are roughly generalizable to the approximately two thirds of the US adult female population bom around 1939-1940 who are non-Hispanic white high school graduates (64) , the unique influence of medical practices and services in the Midwest cannot be ruled out. Our analysis cannot address the potentially different hormone therapy experience of minority group women. Wisconsin Longitudinal Study respondents are also a relatively young midlife sample for studying hormone therapy usage, and to the extent that menopause and use of hormones are age-variant processes we might expect the profile of determinants of hormone use to be different among older women.
Given our relatively advantaged sample, we find it particularly noteworthy that SES-hormone therapy associations were still evident in our analysis. Our results contribute additional support for the hypothesis of an SES gradient in health behaviors and health status (33, 38, 65) and for the hypothesis that race and ethnicity are not adequate proxies for SES in public health data.
It is also noteworthy that SES-hormone therapy associations persisted even when controls were introduced for mental ability, health behaviors, and menopausal symptoms. Although this analysis was not designed to be a detailed examination of all of the potential mediators of the SES-hormone therapy relation, we still found that these three factors did not account for the observed associations.
The extensive measurement of SES-especially the complete and longitudinal coverage of occupational status for women-is an exceptional feature of this study. Which SES measures are most operative in influencing women's use of noncontraceptive hormones? We might have expected that a woman's own characteristics would be more predictive of her health behavior than her family members' characteristics, but our findings suggest otherwise. While a woman's own occupational status was associated with hormone use when it was the only SES measure included in the model (table 2, model 1), when we also controlled for other measures of SES (models 4-6), estimates for respondent's occupational status were reduced in magnitude as well as in significance. However, associations of hormone use with a woman's husband's occupational status were more robust. While the magnitude of the estimates for spouse's occupational status did decrease when other measures of SES were controlled, the associations remained considerable and significant (models 5 and 6).
This presents an interesting question: Holding constant so many other factors (e.g., household income, wealth, respondent's education, menopausal symptoms, health-related behaviors), why are wives of high-status men more likely than other women to use hormone therapy? While we cannot directly address this question in our current analysis, we can consider this finding in light of other research. One typical hypothesis is that women in high SES families are more intensive and regular users of the health care system, that they exhibit better health behaviors, and that hormone therapy is one mechanism whereby women in high SES families engage in a preventive health behavior, yet our analysis included measures for a number of significant health behaviors, and we still found robust effects for husband's occupational status. This casts doubt on the preventive health behavior explanation.
However, given the sociohistorical and ideological context in which hormone therapy has arisen and been promulgated (9) (10) (11) (12) (13) (14) (15) (66) (67) (68) (69) , a competing hypothesis is suggested. A woman with a high occupational status husband may be motivated to maximize her youthfulness and femininity as an additional indicator of her husband's status. Indeed, the early messages about hormone therapy promoted the drugs as promising "eternal beauty and femininity" (12) . While the message of "feminine forever" (68) via hormone therapy may not be as boldly brandished today as it was 30 years ago, hormone therapy is still promoted (66) and possibly still used (31) as a means of preventing conditions considered characteristic of becoming old and less attractive. Is a woman married to a higher-status man consciously or unconsciously more motivated to maintain her youth and femininity than a woman married to a lower-status man? Our data do not allow a definitive answer to this question, but our findings are congruent with a social control theory of health behavior (70, 71), which suggests that health behaviors are better modeled as a function of both social influence and individual characteristics.
In summary, our results suggest that it is important for researchers to include multiple indicators of SES in studies that attempt to understand how social factors help determine women's health-related outcomes. The occupational status of both a woman and her spouse, if she has one, are important measures of SES to include in epidemiologic studies in addition to the woman's educational attainment, household income, and, if possible, wealth. The significance of a woman's parents' SES as well as her husband's SES for her own use of hormones by midlife reconfirm the value of integrating sociologic factors into individual biomedical models of health.
